Please assess the completion status of the following clinical trial:

Trial Title: Patient-Centered Medication Adherence Intervention for Schizophrenia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* medical chart diagnosis of schizophrenia or schizoaffective disorder;~* currently prescribed outpatient antipsychotic medication (oral or depot);~* patient must have adequate capacity to provide informed consent, understand the nature of the study, and sign an informed consent document.~Exclusion Criteria:~- significant cognitive impairment as indicated by a score \> 10 on the Blessed Orientation-Memory-Concentration (BOMC) Test.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Control (Type: NO_INTERVENTION): The control group will receive treatment as usual; meaning patients in the control group will not receive the medication adherence intervention.
- Antipsychotic adherence intervention (Type: EXPERIMENTAL): Antipsychotic Medication Adherence Intervention which included the Barriers, Facilitators, and Motivators Checklist summary and Adherence tips provided in hard copy to patient and electronic copy to mental health provider.

Based on this trial design, predict the completion outcome and termination type (if applicable).